Article
DT(270-326) , a Truncated Diphtheria Toxin, Increases Blood-Tumor Barrier Permeability by Upregulating the Expression of Caveolin-1.
CNS neuroscience & therapeutics - 1 Jun 2016
Lin Yang, Wang Ping, Liu Yun-Hui, Shang Xiu-Li, Chen Liang-Yu, Xue Yi-Xue
Abstract excerpt
AIM: The nontoxic mutant of diphtheria toxin (DT) has been demonstrated to act as a receptor-specific carrier protein to delivery drug into brain. Recent research showed that the truncated "receptorless" DT was still capable of being internalized into cells. This study investigated the effects and potential mechanisms of DT(270-326) , a truncated "receptorless" DT, on the permeability of the blood-tumor barrier...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
